Debate: Is there a Role for Upfront Transplant in the Current Management of Symptomatic Multiple Myeloma?
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Integrate available clinical evidence with development of individualized treatment strategies for patients with multiple myeloma
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center
Sergio A Giralt, MD
Memorial Sloan Kettering Cancer Center
- 0.50 Participation
- 0.60 Nurse
- 0.50 Pharmacist
- 0.50 Physician